• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前影像学检查中可疑淋巴结对肝内胆管癌可切除性、复发及生存的相关性

Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinoma.

作者信息

Bartsch Fabian, Hahn Felix, Müller Lukas, Baumgart Janine, Hoppe-Lotichius Maria, Kloeckner Roman, Lang Hauke

机构信息

Department of General, Visceral and Transplant Surgery, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckst. 1, 55131, Mainz, Germany.

Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

出版信息

BMC Surg. 2020 Apr 15;20(1):75. doi: 10.1186/s12893-020-00730-x.

DOI:10.1186/s12893-020-00730-x
PMID:32295646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7161232/
Abstract

BACKGROUND

Intrahepatic cholangiocarcinoma (ICC) is often diagnosed at an advanced stage resulting in a low resectability rate. Even after potentially curative resection the risk for tumor recurrence is high. Although the extent and value of lymphadenectomy is part of ongoing discussion, the role of preoperative imaging for assessment of suspicious lymph nodes (suspLN) has only been studied modestly. Aim of this study is to demonstrate the influence of suspicious lymph nodes in preoperative imaging on resectability, recurrence, and long-term outcome.

METHODS

All patients who underwent exploration for ICC between January 2008 and June 2018 were included. Preoperative imaging (CT or MRI) was analysed with focus on suspLN at the hepatoduodenal ligament, lesser curvature, interaortocaval, and superior to the diaphragm; suspLN were classified according to the universally accepted RECIST 1.1 criteria; histopathology served as gold standard.

RESULTS

Out of 187 patients resection was performed in 137 (73.3%), in 50 patients the procedure was terminated after exploration. Overall, suspLN were found preoperatively in 73/187 patients (39%). Comparing patients who underwent resection and exploration only, suspLN were significantly more common in the exploration group (p = 0.011). Regarding lymph node stations, significant differences could be shown regarding resectability: All tumors with suspLN superior to the diaphragm were irresectable. Preoperative imaging assessment showed a strong correlation with final histopathology, especially of suspLN of the hepatoduodenal ligament and the lesser curvature. Sensitivity of suspLN was 71.1%, specificity 90.8%. Appearance of tumor recurrence was not affected by suspLN (p = 0.289). Using a short-axis cut-off of <> 1 cm, suspLN had significant influence on recurrence-free survival (RFS, p = 0.009) with consecutive 1-, 3-, and 5-year RFS of 41, 21, and 15% versus 29, 0, and 0%, respectively. Similarly, 1-, 3- and 5-year overall survival (OS) was 75, 30, and 18% versus 59, 18, and 6%, respectively (p = 0.040).

CONCLUSION

Suspicious lymph nodes in preoperative imaging are predictor for unresectability and worse survival. Explorative laparoscopy should be considered, if distant suspicious lymph nodes are detected in preoperative imaging. Nevertheless, given a sensitivity of only 71.1%, detection of suspicious lymph nodes in the preoperative imaging alone is not sufficient to allow for a clear-cut decision against a surgical approach.

摘要

背景

肝内胆管癌(ICC)常于晚期被诊断出来,导致可切除率较低。即使在进行了可能治愈性切除术后,肿瘤复发风险仍很高。尽管淋巴结清扫的范围和价值仍是正在讨论的一部分,但术前影像学检查对可疑淋巴结(suspLN)评估的作用仅得到了有限的研究。本研究的目的是证明术前影像学检查中可疑淋巴结对可切除性、复发及长期预后的影响。

方法

纳入所有在2008年1月至2018年6月期间因ICC接受探查的患者。对术前影像学检查(CT或MRI)进行分析,重点关注肝十二指肠韧带、小弯侧、主动脉腔间隙及膈上的可疑淋巴结;可疑淋巴结根据普遍接受的RECIST 1.1标准进行分类;组织病理学检查作为金标准。

结果

187例患者中,137例(73.3%)进行了切除手术,50例患者在探查后终止了手术。总体而言,73/187例(39%)患者术前发现了可疑淋巴结。仅比较接受切除手术和仅接受探查的患者,可疑淋巴结在探查组中更为常见(p = 0.011)。关于淋巴结部位,在可切除性方面可显示出显著差异:所有膈上有可疑淋巴结的肿瘤均不可切除。术前影像学评估与最终组织病理学检查显示出很强的相关性,尤其是肝十二指肠韧带和小弯侧的可疑淋巴结。可疑淋巴结的敏感性为71.1%,特异性为90.8%。肿瘤复发的出现不受可疑淋巴结的影响(p = 0.289)。使用短轴截断值<> 1 cm时,可疑淋巴结对无复发生存期(RFS,p = 0.009)有显著影响,连续1年、3年和5年的RFS分别为41%、21%和15%,而对照组分别为29%、0%和0%。同样,1年、3年和5年的总生存率(OS)分别为75%、30%和18%,而对照组分别为59%、18%和6%(p = 0.040)。

结论

术前影像学检查中的可疑淋巴结是不可切除性及较差生存率的预测指标。如果术前影像学检查发现远处有可疑淋巴结,应考虑进行探索性腹腔镜检查。然而,鉴于敏感性仅为71.1%,仅通过术前影像学检查发现可疑淋巴结不足以明确决定放弃手术治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/7161232/d745cbcfeb89/12893_2020_730_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/7161232/a5273b782f8e/12893_2020_730_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/7161232/d745cbcfeb89/12893_2020_730_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/7161232/a5273b782f8e/12893_2020_730_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d2d/7161232/d745cbcfeb89/12893_2020_730_Fig2_HTML.jpg

相似文献

1
Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinoma.术前影像学检查中可疑淋巴结对肝内胆管癌可切除性、复发及生存的相关性
BMC Surg. 2020 Apr 15;20(1):75. doi: 10.1186/s12893-020-00730-x.
2
Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.淋巴结清扫术对淋巴结阴性的肝内胆管癌长期预后的预测价值:一项多中心研究。
Surgery. 2019 Dec;166(6):975-982. doi: 10.1016/j.surg.2019.06.025. Epub 2019 Aug 14.
3
Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.常规淋巴结清扫术可能并不适用于所有肝内胆管细胞癌患者:一项单中心系列研究的结果。
World J Gastroenterol. 2013 Dec 21;19(47):9084-91. doi: 10.3748/wjg.v19.i47.9084.
4
Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.肝切除治疗临床淋巴结阴性肝内胆管癌患者时充分淋巴结清扫的生存获益
J Hepatol. 2023 Feb;78(2):356-363. doi: 10.1016/j.jhep.2022.10.021. Epub 2022 Oct 31.
5
Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.对于晚期肝内胆管癌患者可考虑行肝胰十二指肠切除术。
Hepatogastroenterology. 2007 Mar;54(74):346-9.
6
Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma.肝内胆管癌根治性切除术后的淋巴结比率
Br J Surg. 2009 Aug;96(8):919-25. doi: 10.1002/bjs.6654.
7
Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.18-FDG PET/CT在可切除胆管癌管理中的诊断和预后作用
World J Surg. 2018 Mar;42(3):823-834. doi: 10.1007/s00268-017-4192-3.
8
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma.肝门部和肝内胆管癌外科治疗中淋巴结清扫的模式和预后意义。
J Gastrointest Surg. 2013 Nov;17(11):1917-28. doi: 10.1007/s11605-013-2331-1. Epub 2013 Sep 19.
9
Resection of intrahepatic cholangiocarcinoma in elderly patients - is it reasonable?老年患者肝内胆管癌切除术——合理吗?
BMC Surg. 2019 Oct 29;19(1):157. doi: 10.1186/s12893-019-0620-7.
10
Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.乙型肝炎病毒相关性肝内胆管癌切除术后的预后
World J Gastroenterol. 2015 Jan 21;21(3):935-43. doi: 10.3748/wjg.v21.i3.935.

引用本文的文献

1
New Imaging Techniques.新成像技术。
Recent Results Cancer Res. 2023;219:109-145. doi: 10.1007/978-3-031-35166-2_6.
2
A surgical strategy for intrahepatic cholangiocarcinoma - the hilar first concept.肝内胆管癌的一种手术策略 - 肝门优先概念。
Langenbecks Arch Surg. 2023 Aug 7;408(1):296. doi: 10.1007/s00423-023-03023-y.
3
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives.对比增强成像在肝内胆管癌管理中的应用:现状与未来展望

本文引用的文献

1
Surgical Resection for Recurrent Intrahepatic Cholangiocarcinoma.复发性肝内胆管癌的手术切除
World J Surg. 2019 Apr;43(4):1105-1116. doi: 10.1007/s00268-018-04876-x.
2
Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.肝内胆管细胞癌根治性切除术后的预后与内脏浸润密切相关——单中心连续 102 例肝切除术的回顾性队列研究。
Int J Surg. 2018 Jul;55:193-200. doi: 10.1016/j.ijsu.2018.05.027. Epub 2018 May 25.
3
Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma.
Cancers (Basel). 2023 Jun 28;15(13):3393. doi: 10.3390/cancers15133393.
4
Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it's not all about size.预测肝内胆管细胞癌的区域淋巴结转移:大小并非唯一因素。
Abdom Radiol (NY). 2023 Oct;48(10):3063-3071. doi: 10.1007/s00261-023-03991-1. Epub 2023 Jun 24.
5
Effect of lymph node resection on prognosis of resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.淋巴结切除对可切除肝内胆管癌预后的影响:一项系统评价和荟萃分析
Front Oncol. 2022 Sep 27;12:957792. doi: 10.3389/fonc.2022.957792. eCollection 2022.
6
Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients.肿块型肝内胆管癌患者的预后因素:68例病例系列研究
World J Gastrointest Surg. 2022 May 27;14(5):442-451. doi: 10.4240/wjgs.v14.i5.442.
7
Diffusion-weighted imaging as an imaging biomarker for assessing survival of patients with intrahepatic mass-forming cholangiocarcinoma.弥散加权成像作为一种影像学生物标志物,用于评估肝内肿块型胆管细胞癌患者的生存情况。
Abdom Radiol (NY). 2022 Aug;47(8):2811-2821. doi: 10.1007/s00261-022-03569-3. Epub 2022 Jun 15.
8
The role of lymph node dissection in intrahepatic cholangiocarcinoma: a multicenter retrospective study.淋巴结清扫在肝内胆管细胞癌中的作用:一项多中心回顾性研究。
BMC Surg. 2021 Oct 9;21(1):359. doi: 10.1186/s12893-021-01363-4.
9
Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive Review.肝动脉灌注化疗治疗不可切除性肝内胆管癌:一项综述
J Clin Med. 2021 Jun 9;10(12):2552. doi: 10.3390/jcm10122552.
10
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection.肝内胆管细胞癌伴淋巴结转移:治疗相关结局和肿瘤基因组学在患者选择中的作用。
Clin Cancer Res. 2021 Jul 15;27(14):4101-4108. doi: 10.1158/1078-0432.CCR-21-0412. Epub 2021 May 7.
术前标准识别肝内胆管细胞癌淋巴结转移的低危人群。
J Hepatobiliary Pancreat Sci. 2018 Jun;25(6):299-307. doi: 10.1002/jhbp.552. Epub 2018 May 22.
4
Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand.评估泰国胆管癌筛查和护理计划(CASCAP)中包含磁共振成像用于淋巴结转移的术前方案。
World J Surg Oncol. 2017 Sep 20;15(1):176. doi: 10.1186/s12957-017-1246-9.
5
Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.使用18F-氟脱氧葡萄糖正电子发射断层扫描对胆管癌和胆囊癌进行术前分期:一项荟萃分析。
J Investig Med. 2018 Jan;66(1):52-61. doi: 10.1136/jim-2017-000472. Epub 2017 Sep 14.
6
Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System.评估行肝切除术治疗肝内胆管细胞癌患者的淋巴结状态:新版第八版 AJCC 分期系统。
J Gastrointest Surg. 2018 Jan;22(1):52-59. doi: 10.1007/s11605-017-3426-x. Epub 2017 Apr 19.
7
Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database.肝门部胆管癌患者接受扩大肝切除术后淋巴结状态的影响:基于美国国立癌症数据库的综述
HPB (Oxford). 2016 Jan;18(1):79-87. doi: 10.1016/j.hpb.2015.07.006.
8
Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan.肝内胆管癌新分期系统的提议:来自日本肝癌研究组全国性调查的手术患者分析
Cancer. 2016 Jan 1;122(1):61-70. doi: 10.1002/cncr.29686. Epub 2015 Oct 2.
9
Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.既往接受根治性手术切除后复发性肝内胆管癌患者的管理与结局
Ann Surg Oncol. 2016 Jan;23(1):235-43. doi: 10.1245/s10434-015-4642-9. Epub 2015 Jun 10.
10
Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.术前淋巴结肿大对肝内胆管癌的预后影响:九州肝脏外科学术研究组的多机构研究
Ann Surg Oncol. 2015 Jul;22(7):2269-78. doi: 10.1245/s10434-014-4239-8. Epub 2015 Jan 13.